Clinical trial
The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders
NCT00055549 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 4, 2003
- Completion date
- November 13, 2009
- Enrollment
- 65
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.